TipRanks (Tue, 28-Apr 10:00 AM ET)
Agilon Health Names Tim O’Rourke as New CEO
TipRanks (Mon, 27-Apr 4:55 PM ET)
agilon health appoints new CEO
Seeking Alpha News (Mon, 27-Apr 4:26 PM ET)
agilon health Appoints Tim O'Rourke as Chief Executive Officer
Business Wire (Mon, 27-Apr 4:15 PM ET)
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 9-Apr 7:58 PM ET)
agilon health Sets Date to Report First Quarter 2026 Financial Results
Business Wire (Mon, 6-Apr 4:05 PM ET)
Globe Newswire (Tue, 31-Mar 8:15 AM ET)
agilon health Announces Reverse Stock Split
Business Wire (Wed, 18-Mar 4:05 PM ET)
Kuehn Law Encourages Investors of Agilon Health, Inc. to Contact Law Firm
PRNewswire (Thu, 5-Mar 1:12 PM ET)
Globe Newswire (Mon, 2-Mar 4:00 PM ET)
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
Agilon Health trades on the NYSE stock market under the symbol AGL.
As of April 29, 2026, AGL stock price declined to $25.91 with 273,129 million shares trading.
AGL has a beta of 3.70, meaning it tends to be more sensitive to market movements. AGL has a correlation of 0.11 to the broad based SPY ETF.
AGL has a market cap of $431.66 million. This is considered a Small Cap stock.
Last quarter Agilon Health reported $2 billion in Revenue and -$11.50 earnings per share. This beat revenue expectation by $108 million and missed earnings estimates by -$4.75.
In the last 3 years, AGL traded as high as $668.75 and as low as $7.48.
The top ETF exchange traded funds that AGL belongs to (by Net Assets): IWM, FNDA, VTI, IWO, ISMD.
AGL has underperformed the market in the last year with a return of -73.0%, while SPY returned +30.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AGL shares. However, AGL has outperformed the market in the last 3 month and 2 week periods, returning +26.2% and +14.2%, while SPY returned +2.4% and +2.3%, respectively. This indicates AGL has been having a stronger performance recently.
AGL support price is $24.49 and resistance is $31.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGL shares will trade within this expected range on the day.